Literature DB >> 7638811

Prognostic factors influencing the outcome in pneumocystis carinii pneumonia in patients with AIDS.

P Fernandez1, A Torres, J M Miro, C Vieigas, J Mallolas, L Zamora, J M Gatell, M E Valls, R Riquelme, R Rodríguez-Roisin.   

Abstract

BACKGROUND: Studies attempting to identify the prognostic factors that influence the outcome of Pneumocystis carinii pneumonia (PCP) in patients with AIDS using a multivariate analysis are few. In order to identify those prognostic factors amenable to medical intervention, univariate and multivariate analyses were performed on 102 patients with AIDS suffering a first episode of PCP.
METHODS: One hundred and two consecutive patients with AIDS (51% drug abusers, 45% homosexuals, and 4% with other HIV risk factors) admitted to our institution between 1986 and 1989 whose respiratory infection was diagnosed by bronchoalveolar lavage were studied prospectively.
RESULTS: The overall mortality was 28%, rising to 79% in those patients who required mechanical ventilation. According to univariate analysis the following variables were related to a poor prognosis: age > 35 years; risk factor for HIV infection other than drug abuse; and AIDS diagnosis confirmed before 1988; PaO2 < 8 kPa at admission; severe acute respiratory failure on admission (PaO2/FIO2 < 20 kPa); mechanical ventilation; antibiotic therapy for PCP other than trimethoprim-sulphamethoxazole; multiple microbial pulmonary infection; serum lactate dehydrogenase (LDH) > 22.5 mukat/l on admission; serum albumin level < 30 g/l. Multivariate analysis showed that only mechanical ventilation was independently associated with a poor outcome.
CONCLUSIONS: The mortality of AIDS patients presenting with a first episode of PCP before 1990 was high (28%). The main prognostic factor associated with poor outcome was the requirement for mechanical ventilation due to severe acute respiratory failure.

Entities:  

Mesh:

Year:  1995        PMID: 7638811      PMCID: PMC1021269          DOI: 10.1136/thx.50.6.668

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  21 in total

1.  Prognostic indicators in the initial presentation of Pneumocystis carinii pneumonia.

Authors:  S M Garay; J Greene
Journal:  Chest       Date:  1989-04       Impact factor: 9.410

2.  Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome.

Authors:  D E Stover; D A White; P A Romano; R A Gellene; W A Robeson
Journal:  Am J Med       Date:  1985-03       Impact factor: 4.965

3.  Survival and prognostic factors in severe Pneumocystis carinii pneumonia requiring mechanical ventilation.

Authors:  W el-Sadr; M S Simberkoff
Journal:  Am Rev Respir Dis       Date:  1988-06

4.  An expanded definition of the adult respiratory distress syndrome.

Authors:  J F Murray; M A Matthay; J M Luce; M R Flick
Journal:  Am Rev Respir Dis       Date:  1988-09

Review 5.  Pneumocystis carinii pneumonia: therapy and prophylaxis.

Authors:  J A Kovacs; H Masur
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

Review 6.  Radiation carcinogenesis.

Authors:  H I Kohn; R J Fry
Journal:  N Engl J Med       Date:  1984-02-23       Impact factor: 91.245

7.  Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial.

Authors:  J M Wharton; D L Coleman; C B Wofsy; J M Luce; W Blumenfeld; W K Hadley; L Ingram-Drake; P A Volberding; P C Hopewell
Journal:  Ann Intern Med       Date:  1986-07       Impact factor: 25.391

8.  Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.

Authors:  J Mallolas; L Zamora; J M Gatell; J M Miró; E Vernet; M E Valls; E Soriano; J G SanMiguel
Journal:  AIDS       Date:  1993-01       Impact factor: 4.177

Review 9.  Pneumocystis carinii pneumonia: diagnosis.

Authors:  P C Hopewell
Journal:  J Infect Dis       Date:  1988-06       Impact factor: 5.226

10.  Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia.

Authors:  M Brenner; F P Ognibene; E E Lack; J T Simmons; A F Suffredini; H C Lane; A S Fauci; J E Parrillo; J H Shelhamer; H Masur
Journal:  Am Rev Respir Dis       Date:  1987-11
View more
  3 in total

1.  Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006.

Authors:  Peter D Walzer; Hannah E R Evans; Andrew J Copas; Simon G Edwards; Alison D Grant; Robert F Miller
Journal:  Clin Infect Dis       Date:  2008-02-15       Impact factor: 9.079

2.  Risk factors of in-hospital mortality in patients with pneumocystis pneumonia diagnosed by metagenomics next-generation sequencing.

Authors:  Jun-Na Hou; Heng-Dao Liu; Qiu-Yue Tan; Feng-An Cao; Shi-Lei Wang; Meng-Ying Yao; Yang-Chao Zhao
Journal:  Front Cell Infect Microbiol       Date:  2022-09-26       Impact factor: 6.073

3.  Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years.

Authors:  Julius J Schmidt; Catherina Lueck; Stefan Ziesing; Matthias Stoll; Hermann Haller; Jens Gottlieb; Matthias Eder; Tobias Welte; Marius M Hoeper; André Scherag; Sascha David
Journal:  Crit Care       Date:  2018-11-19       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.